RhumbLine Advisers’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Buy |
|
|||||
|
2025
Q1 | $239K | Buy |
|
|||||
|
2024
Q4 | $403K | Sell |
|
|||||
|
2024
Q3 | $688K | Sell |
|
|||||
|
2024
Q2 | $657K | Sell |
|
|||||
|
2024
Q1 | $898K | Buy |
|
|||||
|
2023
Q4 | $368K | Sell |
|
|||||
|
2023
Q3 | $299K | Buy |
|
|||||
|
2023
Q2 | $358K | Buy |
|
|||||
|
2023
Q1 | $244K | Sell |
|
|||||
|
2022
Q4 | $238K | Buy |
|
|||||
|
2022
Q3 | $675K | Buy |
|
|||||
|
2022
Q2 | $658K | Buy |
|
|||||
|
2022
Q1 | $429K | Sell |
|
|||||
|
2021
Q4 | $590K | Sell |
|
|||||
|
2021
Q3 | $1.06M | Buy |
|
|||||
|
2021
Q2 | $1.18M | Sell |
|
|||||
|
2021
Q1 | $1.08M | Sell |
|
|||||
|
2020
Q4 | $1.91M | Buy |
|
|||||
|
2020
Q3 | $1.4M | Sell |
|
|||||
|
2020
Q2 | $1.81M | Buy |
|
|||||
|
2020
Q1 | $732K | Buy |
|
|||||
|
2019
Q4 | $851K | Buy |
|
|||||
|
2019
Q3 | $575K | Buy |
|
|||||
|
2019
Q2 | $490K | Buy |
|